Yet another CRO giant has taken a revenue hit due to a customer demand dip. | Yet another CRO giant has taken a revenue hit ...

Amid the launch of its first over-the-counter wearable glucose tracker, Dexcom reported that its overall revenues in the U.S.

Less than a year after obtaining an FDA approval for its first foray into pulsed field ablation, Medtronic has done it again.

While cryptosporidiosis, infection by the protist parasite Cryptosporidium, is rare in the United States, it is a common ...

Septerna CEO Jeffrey Finer rang the opening bell on the Nasd | South San Francisco-based Septerna has scored with an upsized ...

AbbVie has returned to the source of its antipsychotic powerhouse Vraylar in search of another blockbuster, paying $25 ...

GenSight Biologics is weeks away from running out of money. Again. | GenSight Biologics is weeks away from running out of ...

Shiny new Jade Biosciences has selected its CEO in Tom Frohlich, who co-founded Chinook Therapeutics and served as chief ...

With new data out on Arcus Biosciences’ experimental HIF-2a inhibitor, one group of analysts figures the company could give ...

Monopar Therapeutics is recovering a drug from the scrap heap of AstraZeneca’s rare disease pipeline. | Monopar Therapeutics ...

Lundbeck is slashing the book value of its $250 million Abide Therapeutics buyout in response to phase 1 data that triggered ...

After forming a gene therapy partnership with Dyno Therapeutics in 2020, Roche is back for more. | In a new deal potentially ...